APA
Takimoto C. H., Morrison G., Harold N., Quinn M., Monahan B. P., Band R. A., Cottrell J., Guemei A., Llorens V., Hehman H., Ismail A. S., Flemming D., Gosky D. M., Hirota H., Berger S. J., Berger N. A., Chen A. P., Shapiro J. D., Arbuck S. G., Wright J., Hamilton J. M., Allegra C. J. & Grem J. L. (20000229). Phase I and pharmacologic study of irinotecan administered as a 96-hour infusion weekly to adult cancer patients. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Chicago
Takimoto C H, Morrison G, Harold N, Quinn M, Monahan B P, Band R A, Cottrell J, Guemei A, Llorens V, Hehman H, Ismail A S, Flemming D, Gosky D M, Hirota H, Berger S J, Berger N A, Chen A P, Shapiro J D, Arbuck S G, Wright J, Hamilton J M, Allegra C J and Grem J L. 20000229. Phase I and pharmacologic study of irinotecan administered as a 96-hour infusion weekly to adult cancer patients. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Harvard
Takimoto C. H., Morrison G., Harold N., Quinn M., Monahan B. P., Band R. A., Cottrell J., Guemei A., Llorens V., Hehman H., Ismail A. S., Flemming D., Gosky D. M., Hirota H., Berger S. J., Berger N. A., Chen A. P., Shapiro J. D., Arbuck S. G., Wright J., Hamilton J. M., Allegra C. J. and Grem J. L. (20000229). Phase I and pharmacologic study of irinotecan administered as a 96-hour infusion weekly to adult cancer patients. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
MLA
Takimoto C H, Morrison G, Harold N, Quinn M, Monahan B P, Band R A, Cottrell J, Guemei A, Llorens V, Hehman H, Ismail A S, Flemming D, Gosky D M, Hirota H, Berger S J, Berger N A, Chen A P, Shapiro J D, Arbuck S G, Wright J, Hamilton J M, Allegra C J and Grem J L. Phase I and pharmacologic study of irinotecan administered as a 96-hour infusion weekly to adult cancer patients. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20000229.